A Double Blind, Randomised, Parallel Group, Placebo Controlled Study of Sativex in the Treatment of Central Neuropathic Pain in Multiple Sclerosis.
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2014
At a glance
- Drugs Nabiximols (Primary)
- Indications Central pain; Multiple sclerosis
- Focus Therapeutic Use
- Sponsors GW Pharmaceuticals
- 05 Nov 2010 New trial record.